Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1970 2
1971 2
1973 1
1975 1
1977 2
1981 1
1982 3
1983 3
1984 4
1985 4
1986 6
1987 4
1990 5
1991 1
1992 3
1995 1
1996 2
1997 1
1998 3
1999 8
2000 2
2001 4
2002 1
2003 6
2004 7
2005 6
2006 5
2007 5
2008 10
2009 13
2010 10
2011 19
2012 28
2013 28
2014 17
2015 19
2016 14
2017 10
2018 8
2019 17
2020 22
2021 30
2022 36
2023 14
2024 13
2025 23
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.
Carturan A, Angelos MG, Guruprasad P, Patel RP, Pajarillo R, Lee AE, Espie D, Zhang Y, Chiang YH, Xie W, Rodriguez JL, Harris J, Devi P, Afolayan-Oloye OI, Xu J, Sussman JH, Elghawy O, Yang AG, Barsouk A, Cho JH, Shaw CE, Singh EB, Ugwuanyi O, Paruzzo L, Stella F MD, Liu S, Nason S, Imparato A, Rotolo A, Lemoine J, Barrett DM, Posey AD Jr, Rook AH, Pillai V, Bagg A, Pileri SA, Liu D, Tan K, Schuster SJ, Teachey DT, Porazzi P, Ruella M. Carturan A, et al. Among authors: stella f md. Blood. 2026 Jan 5:blood.2025031409. doi: 10.1182/blood.2025031409. Online ahead of print. Blood. 2026. PMID: 41490267
Outcomes of relapse after teclistamab therapy in multiple myeloma.
Yu KL, Ho M, Paruzzo L, Stella F, Patel H, Hasanali ZS, Kapur S, Waxman AJ, Vogl DT, Stadtmauer EA, Fraietta JA, Ruella M, Cohen AD, Garfall AL, Susanibar-Adaniya S. Yu KL, et al. Among authors: stella f. Blood Cancer J. 2025 Nov 5;15(1):193. doi: 10.1038/s41408-025-01408-4. Blood Cancer J. 2025. PMID: 41188250 Free PMC article. No abstract available.
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee.
Damaj G, de Masson A, Dreger P, Bazarbachi A, Berning P, Duarte RF, Fox CP, Guenova E, Hermine O, Kyriakou C, Tanase A, Tournilhac O, Jurczak W, Karsten IE, Quoc SN, Serroukh Y, Stella F, Wulf G, Sureda A, Papadavid E, Ortiz-Romero PL, Ruggeri A, Sánchez-Ortega I, Scarisbrick JJ, Yakoub-Agha I, Onida F, Schmitz N. Damaj G, et al. Among authors: stella f. Bone Marrow Transplant. 2025 Dec;60(12):1565-1573. doi: 10.1038/s41409-025-02696-x. Epub 2025 Oct 1. Bone Marrow Transplant. 2025. PMID: 41034407 Free PMC article. Review.
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee.
Damaj G, de Masson A, Dreger P, Bazarbachi A, Berning P, Duarte RF, Fox CP, Guenova E, Hermine O, Kyriakou C, Tanase A, Tournilhac O, Jurczak W, Karsten IE, Quoc SN, Serroukh Y, Stella F, Wulf G, Sureda A, Papadavid E, Ortiz-Romero PL, Ruggeri A, Sánchez-Ortega I, Scarisbrick JJ, Yakoub-Agha I, Onida F, Schmitz N. Damaj G, et al. Among authors: stella f. J Eur Acad Dermatol Venereol. 2025 Oct 1. doi: 10.1111/jdv.70042. Online ahead of print. J Eur Acad Dermatol Venereol. 2025. PMID: 41031482 Review.
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.
Dodero A, Ceparano G, Casadei B, Angelillo P, Bramanti S, Tisi MC, Ljevar S, Stella F, Chiappella A, Botto B, Cutini I, Zanirato G, Chiusolo P, Barbui AM, Farina M, Di Rocco A, Grillo G, Olivieri J, Krampera M, Ladetto M, Guidetti A, Zinzani PL, Carniti C, Corradini P. Dodero A, et al. Among authors: stella f. Blood Adv. 2025 Dec 23;9(24):6491-6501. doi: 10.1182/bloodadvances.2025016117. Blood Adv. 2025. PMID: 40763273 Free PMC article.
Allogeneic transplantation after failure of chimeric antigen receptor-T cells and exposure to bispecific antibodies: Feasibility, safety and survival outcomes.
Barone A, De Philippis C, Stella F, Dodero A, Sarina B, Pennisi M, Santoro A, Carlo-Stella C, Guidetti A, Bramanti S, Corradini P. Barone A, et al. Among authors: stella f. Br J Haematol. 2025 Sep;207(3):956-964. doi: 10.1111/bjh.70010. Epub 2025 Jul 22. Br J Haematol. 2025. PMID: 40695357 Free PMC article.
375 results